Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
74
ESQ Quote, Financials, Valuation and Earnings
Last price:
$100.08
Seasonality move
:
10.8%
Day range:
$97.21 - $100.55
52-week range:
$54.49 - $101.35
Dividend yield:
0.65%
P/E ratio:
18.91x
P/S ratio:
6.60x
P/B ratio:
3.38x
Volume:
135.6K
Avg. volume:
147.5K
1-year change:
76.83%
Market cap:
$846.4M
Revenue:
$124.8M
EPS (TTM):
$5.29
Earnings Data
Next earnings date for ESQ
Jul 25
2025
Most recent earnings per share
$1.33
Beat by $0.02
(Apr 24/2025)
Consensus Estimate
$1.31
(Apr 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ESQ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $28.8M | -- | -- | $1.42 | -- |
| 07/25/2025 | Q2 | $28.3M | -- | -- | $1.38 | -- |
| 04/24/2025 | Q1 | $30.7M | $33.8M | $1.33 | $1.31 | $0.02 |
| 01/23/2025 | Q4 | $26.8M | $33.1M | $1.37 | $1.38 | -$0.01 |
| 10/24/2024 | Q3 | $27.3M | $31.9M | $1.34 | $1.31 | $0.03 |
| 07/25/2024 | Q2 | $23.5M | $30.6M | $1.25 | $1.19 | $0.06 |
| 04/25/2024 | Q1 | $22.7M | $29.3M | $1.20 | $1.17 | $0.03 |
| 01/25/2024 | Q4 | $22.3M | $28.9M | $1.18 | $1.17 | $0.01 |
| 10/23/2023 | Q3 | -- | -- | $1.17 | $1.13 | $0.04 |
| 07/25/2023 | Q2 | -- | -- | $1.10 | $1.05 | $0.05 |
| 04/25/2023 | Q1 | -- | -- | $1.47 | $0.94 | $0.53 |
| 01/25/2023 | Q4 | -- | -- | $1.10 | $0.99 | $0.12 |
| 10/25/2022 | Q3 | -- | -- | $0.94 | $0.86 | $0.09 |
| 07/25/2022 | Q2 | -- | -- | $0.78 | $0.71 | $0.07 |
| 04/25/2022 | Q1 | -- | -- | $0.66 | $0.65 | $0.01 |
| 01/25/2022 | Q4 | -- | -- | $0.83 | $0.65 | $0.18 |
| 10/25/2021 | Q3 | -- | -- | $0.32 | $0.62 | -$0.30 |
| 07/26/2021 | Q2 | -- | -- | $0.57 | $0.56 | $0.01 |
| 04/26/2021 | Q1 | -- | -- | $0.53 | $0.50 | $0.03 |
| 01/25/2021 | Q4 | -- | -- | $0.51 | $0.51 | -- |
| 10/23/2020 | Q3 | -- | -- | $0.48 | $0.48 | -- |
| 07/24/2020 | Q2 | -- | -- | $0.33 | $0.44 | -$0.11 |
| 04/24/2020 | Q1 | -- | -- | $0.33 | $0.48 | -$0.15 |
| 01/24/2020 | Q4 | -- | -- | $0.50 | -- | -- |
| 10/25/2019 | Q3 | -- | -- | $0.49 | $0.47 | $0.02 |
| 07/25/2019 | Q2 | -- | -- | $0.45 | $0.41 | $0.04 |
| 04/25/2019 | Q1 | -- | -- | $0.39 | $0.37 | $0.02 |
| 01/25/2019 | Q4 | -- | -- | $0.37 | $0.37 | -- |
| 10/25/2018 | Q3 | -- | -- | $0.33 | $0.33 | -- |
| 07/25/2018 | Q2 | -- | -- | $0.29 | $0.29 | -- |
| 04/25/2018 | Q1 | -- | -- | $0.26 | $0.25 | $0.01 |
Esquire Financial Holdings Earnings Questions
-
How Much did Esquire Financial Holdings Generate in Revenue Last Quarter?
Esquire Financial Holdings reported $33.8M worth of top line sales in its most recent quarter.
-
Did Esquire Financial Holdings Beat Earnings Last Quarter?
Esquire Financial Holdings announced earnings per share of $1.33 which represents a beat of analyst forecast a $1.31 per share.
-
Is Esquire Financial Holdings Profitable?
Esquire Financial Holdings reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Esquire Financial Holdings EPS Next Year?
Esquire Financial Holdings's earnings are forecast to grow from $5.14 per share to $5.16 per share next year representing an increase of 8.11%.
-
When is Esquire Financial Holdings's Earnings Date?
Esquire Financial Holdings's next earnings date is July 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
